Feb. 28 Nine months ended Feb. 28
2009 2008 2009 2008
Revenue
Food Safety $14,173 $13,835 $45,101 $42,068
Animal Safety 13,667 11,345 42,730 33,231
Total revenue 27,840 25,180 87,831 75,299
Cost of sales 14,813 12,517 43,875 36,168
Gross margin 13,027 12,663 43,956 39,131
Other expenses
Sales & marketing 5,422 4,947 17,053 15,081
Administrative 2,769 2,717 8,382 7,909
Research & development 1,265 1,018 3,436 2,815
Total other expenses 9,456 8,682 28,871 25,805
Operating income 3,571 3,981 15,085 13,326
Other income 602 2 1,047 472
Income before tax 4,173 3,983 16,132 13,798
Income tax 1,350 1,325 5,675 4,875
Net income $2,823 $2,658 $10,457 $8,923
Net income per diluted
Share $0.19 $0.18 $0.69 $0.60
Other information:
Shares to calculate
per share 15,097 14,918 15,078 14,792
Depreciation &
Amortization $942 $944 $2,892 $2,583
Interest expense 0 0 0 0
Gross margin (% of
sales) 46.8% 50.3% 50.0% 52.0%
Operating income (% of
sales) 12.8% 15.8% 17.2% 17.7%
Revenue increase vs.
FY 2008 10.6% 16.6%
Net income increase
vs. FY 2008 6.2% 17.2%
NEOGEN CORPORATION UNAUDITED SUMMARIZED C
'/>"/>SOURCE Neogen Corporation Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 Related biology technology :1.
Neogen Acquires Kane Enterprises2.
Neogen Reports 25% Increase in Net Income, 13% Increase in Revenues3.
Neogen Acquires Assets of Rivard Instruments4.
Neogen Reports 34% Increase in Net Income, 23% Increase in Revenues5.
Neogen Launches Quickest Test Available for Tetracyclines in Milk6.
NeoGenomics Announces Results for the Fourth Quarter and Full Year FY 20077.
Webcast Alert: Neogen Corporation Announces 3rd Quarter Results8.
Neogen Reports 34% Increase in Net Income, 20% Increase in Revenues9.
NeoGenomics Files Annual Report on Form 10-KSB with the SEC10.
NeoGenomics Schedules Its Q1 2008 Earnings Release for May 7, 200811.
Neogen Forms Mexican Subsidiary